Moss J - Search Results

1

Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user.

Ladanyi A, Temkin SM, Moss J. Ladanyi A, et al. Among authors: moss j. Int J Gynecol Cancer. 2010 Feb;20(2):308-10. doi: 10.1111/IGC.0b013e3181cd1828. Int J Gynecol Cancer. 2010. PMID: 20134275

2

Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation.

Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Singleton PA, et al. Among authors: moss j. Microvasc Res. 2006 Jul-Sep;72(1-2):3-11. doi: 10.1016/j.mvr.2006.04.004. Epub 2006 Jul 3. Microvasc Res. 2006. PMID: 16820176

3

Methylnaltrexone prevents morphine-induced kaolin intake in the rat.

Aung HH, Mehendale SR, Xie JT, Moss J, Yuan CS. Aung HH, et al. Among authors: moss j. Life Sci. 2004 Apr 16;74(22):2685-91. doi: 10.1016/j.lfs.2003.08.047. Life Sci. 2004. PMID: 15043984

4

Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexone.

Woo M, O'Connor M, Yuan CS, Moss J. Woo M, et al. Among authors: moss j. Anesth Analg. 2008 Dec;107(6):1965-7. doi: 10.1213/ane.0b013e31818556d3. Anesth Analg. 2008. PMID: 19020145

5

Safety and tolerance of methylnaltrexone in healthy humans: a randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study.

Foss JF, O'Connor MF, Yuan CS, Murphy M, Moss J, Roizen MF. Foss JF, et al. Among authors: moss j. J Clin Pharmacol. 1997 Jan;37(1):25-30. doi: 10.1177/009127009703700105. J Clin Pharmacol. 1997. PMID: 9048269 Clinical Trial.

6

Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.

Yuan CS, Doshan H, Charney MR, O'connor M, Karrison T, Maleckar SA, Israel RJ, Moss J. Yuan CS, et al. Among authors: moss j. J Clin Pharmacol. 2005 May;45(5):538-46. doi: 10.1177/0091270004273491. J Clin Pharmacol. 2005. PMID: 15831777 Clinical Trial.

7

The mu opioid receptor: A new target for cancer therapy?

Singleton PA, Moss J, Karp DD, Atkins JT, Janku F. Singleton PA, et al. Among authors: moss j. Cancer. 2015 Aug 15;121(16):2681-8. doi: 10.1002/cncr.29460. Epub 2015 Jun 4. Cancer. 2015. PMID: 26043235 Free article. Review.

8

Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone.

Moss J. Moss J. Anesthesiology. 2019 Jan;130(1):142-148. doi: 10.1097/ALN.0000000000002428. Anesthesiology. 2019. PMID: 30277930 Free article. Clinical Trial.

Methylnaltrexone Reverses Chronic Opioid-induced Constipation: A Randomized, Controlled Trial. By Yuan CS, Foss JF, O'Connor M, Osinski J, Karrison T, Moss J, Roizen MF. JAMA 2000; 130:142-8. Reprinted with permission. ...

Methylnaltrexone Reverses Chronic Opioid-induced Constipation: A Randomized, Controlled Trial. By Yuan CS, Foss JF, O'Connor M, Osinski J …

9

Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.

Singleton PA, Moreno-Vinasco L, Sammani S, Wanderling SL, Moss J, Garcia JG. Singleton PA, et al. Among authors: moss j. Am J Respir Cell Mol Biol. 2007 Aug;37(2):222-31. doi: 10.1165/rcmb.2006-0327OC. Epub 2007 Mar 29. Am J Respir Cell Mol Biol. 2007. PMID: 17395891

10

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.

Janku F, Johnson LK, Karp DD, Atkins JT, Singleton PA, Moss J. Janku F, et al. Among authors: moss j. Ann Oncol. 2016 Nov;27(11):2032-2038. doi: 10.1093/annonc/mdw317. Epub 2016 Aug 29. Ann Oncol. 2016. PMID: 27573565 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,767 results

Search Page